Erik Hooijberg

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Venues

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer immunology, immunotherapy : CII

Oncoimmunology

Antoni van Leeuwenhoek Nederlands Kanker Instituut

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Antoni van Leeuwenhoek Nederlands Kanker Instituut Feb 01 2018

Netherlands

Immunologist imaging tumormicroenvironments :: Pathology

Publications

Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, Iris M Seignette, Jan-Jaap J Mellema, Maartje Alkemade, Alberto Gil-Jimenez, Dennis Peters, Wim Brugman, Chantal F Stockem, Erik Hooijberg, Annegien Broeks, Bas W G van Rhijn, Laura S Mertens, Antoine G Van der Heijden, Niven Mehra, Maurits L van Montfoort, Lodewyk F A Wessels, Daniel J Vis, Michiel S Van Der Heijden
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Hielke Martijn de Vries, Tynisha S Rafael, Alberto Gil-Jimenez, Jeantine M de Feijter, Elise Bekers, Elsbeth van der Laan, Marta Lopez-Yurda, Erik Hooijberg, Annegien Broeks, Dennis Peters, Iris M Seignette, Floris J Pos, Simon Horenblas, Bas W G van Rhijn, Ekaterina S Jordanova, Oscar R Brouwer, Eva Schaake, Michiel S Van Der Heijden
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Eline J H van Houtum, Esther D Kers-Rebel, Maaike W Looman, Erik Hooijberg, Christian Büll, Daniel Granado, Lenneke A M Cornelissen, Gosse J Adema
Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7. Cellular and molecular life sciences : CMLS 80 (6) (2023)
Hanne Lefrère, Kat S Moore, Giuseppe Floris, Joyce Sanders, Iris M Seignette, Tycho Bismeijer, Dennis Peters, Annegien Broeks, Erik Hooijberg, Kristel Van Calsteren, Patrick Neven, Ellen Warner, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Sileny N Han, Katarzyna Joanna Jerzak, Daniela Annibali, Diether Lambrechts, Karin E de Visser, Lodewyk F A Wessels, Liesbeth Lenaerts, Frédéric Amant
Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Mathilde M M Almekinders, Michael Schaapveld, Bram Thijssen, Lindy L Visser, Tycho Bismeijer, Joyce Sanders, Edoardo Isnaldi, Ingrid Hofland, Marjolijn Mertz, Lodewyk F A Wessels, Annegien Broeks, Erik Hooijberg, Wilbert Zwart, Esther H Lips, null null, Christine Desmedt, Jelle Wesseling
Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ. NPJ breast cancer 7 (1) (2021)
Joris L Vos, Joris B W Elbers, Oscar Krijgsman, Joleen J H Traets, Xiaohang Qiao, Anne M van der Leun, Yoni Lubeck, Iris M Seignette, Laura A Smit, Stefan M Willems, Michiel W M van den Brekel, Richard Dirven, M Baris Karakullukcu, Luc Karssemakers, W Martin C Klop, Peter J F M Lohuis, Willem H Schreuder, Ludi E Smeele, Lilly-Ann van der Velden, I Bing Tan, Suzanne Onderwater, Bas Jasperse, Wouter V Vogel, Abrahim Al-Mamgani, Astrid Keijser, Vincent van der Noort, Annegien Broeks, Erik Hooijberg, Daniel S Peeper, Ton N M Schumacher, Christian U Blank, Jan Paul de Boer, John B A G Haanen, Charlotte L Zuur
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma. Nature communications 12 (1) (2021)
Nick van Dijk, Alberto Gil-Jimenez, Karina Silina, Kees Hendricksen, Laura A Smit, Jeantine M de Feijter, Maurits L van Montfoort, Charlotte van Rooijen, Dennis Peters, Annegien Broeks, Henk G van der Poel, Annemarie Bruining, Yoni Lubeck, Karolina Sikorska, Thierry N Boellaard, Pia Kvistborg, Daniel J Vis, Erik Hooijberg, Ton N M Schumacher, Maries van den Broek, Lodewyk F A Wessels, Christian U Blank, Bas W van Rhijn, Michiel S Van Der Heijden
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nature medicine 26 (12) (2020)
Bianca Cioni, Anniek Zaalberg, Judy R van Beijnum, Monique H M Melis, Johan van Burgsteden, Mauro J Muraro, Erik Hooijberg, Dennis Peters, Ingrid Hofland, Yoni Lubeck, Jeroen de Jong, Joyce Sanders, Judith Vivié, Henk G van der Poel, Jan Paul de Boer, Arjan W Griffioen, Wilbert Zwart, Andries M Bergman
Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion. Nature communications 11 (1) (2020)
Bas D Koster, Saskia J A M Santegoets, Jorien Harting, Arnold Baars, S Marieke van Ham, Rik J Scheper, Erik Hooijberg, Tanja D de Gruijl, Alfonsus J M van den Eertwegh
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. Cancer immunology, immunotherapy : CII 68 (6) (2019)
Marcelo Sobral-Leite, Koen K van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K J Hooijer, Hugo Mark Horlings, Tesa M Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino-Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J van de Vijver, René Bernards, Irene L Andrulis, Marleen Kok, Karin E de Visser, Marjanka K Schmidt
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. Oncoimmunology 7 (12) (2018)
Bianca Cioni, Ekaterina S Jordanova, Erik Hooijberg, Rianne van der Linden, Renee X de Menezes, Katherine Tan, Stefan Willems, Joris B W Elbers, Annegien Broeks, Andries M Bergman, Charlotte L Zuur, Jan Paul de Boer
HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer. Head & neck 41 (2) (2018)

Erik Hooijberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Erik Hooijberg